Diffuse Large B-cell Lymphoma Presenting with Hypercalcemia and Multiple Osteolysis

References

• Roodmann, G.D. (2001) "Biology of osteoclast activation in cancer", Journal of Clinical Oncology, 19, 3562— 3571.
   Google Scholar
• Yaccoby, S., Pearse, RN., Johnson, CL., Barlogie, B., Choi, Y. and Epstein, J. (2002) "Myeloma interacts with the bone marrow microenvironment to induce osteoclastogenesis and is dependent on osteoclast activity", British Journal of Haematology, 116, 278 — 290.
   Google Scholar
• Choi, Si., Cruz, J.C., Craig, F., Chung, H., Devlin, R.D., Roodman, G.D., et al. (2000) "Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma", Blood, 96, 671 — 675.
   Google Scholar
• Abe, M., Hiura, K., Wilde, J., Moriyama, K., Hashimoto, T., Ozaki, S., et al. (2002) "Role for Macrophage inflammatory protein (MIP)- 1 a and MIP-1/3 in the development of osteolytic lesions in multiple myeloma", Blood, 100, 2195–2202.
   PubMed Web of Science ®Google Scholar
• Uneda, S., Hata, H., Matsuno, F., Harada, N., Mitsuya, Y., Kawano, F., et al. (2003) "Macrophage inflammatory protein-1 alpha is produced by human multiple myeloma (MM) cells and its expression correlates with bone lesions in patients with MM", British Journal of Haematology, 120, 53–55.
   PubMed Web of Science ®Google Scholar
• Firkin, F., Schneider, H. and Grill, V. (1998) "Parathyroid hormone-related protein in hypercalcemia associated with hemato-logical malignancy", Leukemia and Lymphoma, 29, 499 — 506.
   Google Scholar
• Seymour, J.F. and Gagel, R.F. (1993) "Calcitriol: the major humoral mediator of hypercalcemia in Hodgkin's disease and non-Hodgkin's lymphomas", Blood, 82, 1383— 1394.
   Google Scholar
• Roux, S. and Mariette, X. (2000) "Hematological malignancies and the bone (myeloma excluded)", Joint Bone Spine, 67, 264 — 271.
   Google Scholar
• Gravallese, EM., Manning, C., Tsay, A., Naito, A., Pan, C., Amento, E., et al. (2000) "Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor", Arthritis and Rheuma-tism, 43, 250–258.
   PubMed Web of Science ®Google Scholar
• Taichman, R.S., Reilly, M.J. and Emerson, S.G. (1997) "Human osteosarcomas inhibit hematopoietic colony formation: Partial reversal by antibody to transforming growth factor-el", Bone, 21, 353— 361.
   Google Scholar
• Schmidtmayerova, H., Nottet, H.S., Nuovo, G., Raabe, T., Flanagan, C.R., Dubrovsky, L., et al. (1996) "Human immunode-ficiency virus type 1 infection alters chemokine 13 peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes", Proceedings of the National Academy of Sciences of the United States of America, 93, 700–704.
   PubMed Web of Science ®Google Scholar
• Dankbar, B., Padro, T., Leo, R., Feldmann, B., Kropff, M., Mesters, R.M., et al. (2000) "Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma", Blood, 95, 2630–2636.
   PubMed Web of Science ®Google Scholar
• Taichman, R.S. and Emerson, S.G. (1996) "Human osteosarcoma cell lines MG-63 and Sa0S-2 produce G-CSF and GM-CSF: identification and partial characterization of cell-associated iso-fo rms", Experimental Hematology, 24, 509 — 517.
   Google Scholar
• Ohmori, M., Nagai, M., Fujita, M., Dobashi, H., Tasaka, T., Yamaoka, G., et al. (1998) "A novel mature B-cell line (DOBIL-6) producing both parathyroid hormone-related protein and inter-leukin-6 from a myeloma patient presenting with hypercalcemia", British Journal of Haematology, 101, 688–693.
   PubMed Web of Science ®Google Scholar
• Huang, Y.T., Sheen, T.S., Chen, C.L., Lu, J., Chang, Y., Chen, J.Y., et al. (1999) "Profile of cytokine expression in nasopharyngeal carcinomas: a distinct expression of interleukin 1 in tumor and CD4± T cells", Cancer Research, 59, 1599–1605.
   Google Scholar
• Zeng, Q., Smith, D.C., Suscovich, T.J., Gooding, WE., Trump, D.L. and Grandis, J.R. (2000) "Determination of intermediate biomarker expression levels by quantitative reverse transcription-polymerase chain reaction in oral mucosa of cancer patients treated with liarozole", Clinical Cancer Research, 6, 2245–2251.
   Google Scholar
• Sensebe, L., Deschaseaux, M., Li, J., Herve, P. and Charbord, P. (1997) "The broad spectrum of cytokine gene expression by myoid cells from the human marrow microenvironment", Stem Cells, 15, 133–143.
   Google Scholar
• Callander, N.S. and Roodman, G.D. (2001) "Myeloma bone disease", Seminars in Hematology, 38, 276–285.
   PubMed Web of Science ®Google Scholar
• Sezer, O., Heider, U., Zavrski, I., Kuhne, C.A. and Hofbauer, L.C. (2003) "RANK ligand and osteoprotegerin in myeloma bone disease", Blood, 101, 2094–2098.
   Google Scholar
• Nosaka, K., Miyamoto, T., Sakai, T., Mitsuya, H., Suda, T. and Matsuoka, M. (2002) "Mechanism of hypercalcemia in adult T-cell leukemia: overexpression of receptor activator of nuclear factor KB ligand on adult T-cell leukemia cells", Blood, 99, 634–640.
   Google Scholar
• Fiumara, P., Snell, V., Li, Y., Mukhopadhyay, A., Younes, M., Gillenwater, A.M., et al. (2001) "Functional expression of receptor activator of nuclear factor kappaB in Hodgkin disease cell lines", Blood, 98, 2784–2790.
   Google Scholar
• Han, J.H., Choi, S.J., Kurihara, N., Koide, M., Oba, Y. and Roodman, G.D. (2001) "Macrophage inflammatory protein 1-a is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor KB ligand", Blood, 97, 3349 — 3353.
   Google Scholar